Several weeks after a hysterectomy last spring, Bo Roth was suffering from exhaustion and pain that kept her on the couch much of the day. The 58-year-old Seattle speech coach didn’t want to take opioid pain-killers, but Tylenol wasn’t helping enough. Roth was intrigued when women in her online chat group enthused about a cannabis-derived oil called cannabidiol (CBD) that they said relieved pain without making them high. So Roth, who hadn’t smoked weed since college but lived in a state where cannabis was legal, walked into a dispensary and bought a CBD tincture.
Homeostasis is non-negotiable for your health. When your ECS isn’t working properly it may lead to a variety of problems inside your body. Clinical encodcannabionoid deficiency (CECD) refers to a variety of conditions related to an ECS that is not working optimally. CECD conditions may include fibromyalgia, migraines, irritable bowel syndrome (IBD), and other health issues that may cause pain in your body.
The disturbing problem regarding the current status of cannabidiol is expressed in the same source. Institutional endeavors by the Food and Drug Administration to classify it as a drug are in its infancy. Nevertheless, this should mean that CBD could no longer be marketed as a dietary supplement, as that class of products is subject to ridiculously lax regulation. However, there are countless companies (some no larger than a newsstand, while others are listed on the stock exchange) that sell supplements containing cannabidiol (as oil, capsules, sprays, etc.) unencumbered by either state or federal authorities.
Today, it’s mostly used as a supplement that promotes overall health and has anticonvulsant, anti-inflammatory, and anti-anxiety properties. CBD is also recommended as a natural pain relief medicine. It has been reported to aid the relief of severe conditions like cancer and AIDS. Furthermore, CBD can lessen the negative side effects of the chemotherapy treatment.
However, before the villainization of hemp, it was widely accepted as a very useful plant (3). From biofuel from its seeds to medicine from its leaves, it ought to be a core crop grown by farmers across the United States and beyond. However, for reasons too numerous to discuss in this article, issues of legality and federal restrictions have put a stop to that idea for the time being.
A survey of patients seen in a tertiary epilepsy center found that 21% of patients admitted to using marijuana in the last year, and 24% of patients believed marijuana to be effective for their seizures (10). While interesting, this anecdotal observation does not rise to the level of evidence needed to evaluate a potential new therapeutic modality.